Match the respiratory condition with its hallmark symptom.

Step 1 is: 520 mL÷ 8 hours = 65 mL/hr.

Step 2 is: 65 mL/hr÷ 42 kg = 1.5476. mL/kg/hr.

Step 3 is: Round the result to the nearest tenth: 1.5 mL/kg/hr. Final calculated answer: 1.5.

Choice A rationale

Cyanosis, a bluish discoloration of the skin and mucous membranes, indicates significant hypoxemia (low oxygen saturation) and is a sign of severe, life-threatening asthma exacerbation, not a mild to moderate presentation. In mild to moderate asthma, the body can usually compensate to maintain adequate tissue oxygenation despite airway constriction and inflammation.

Choice B rationale

Chest tightness is a subjective but common symptom in asthma, resulting from the bronchoconstriction and smooth muscle spasm that narrow the airways. The sensation is often described as a band around the chest, reflecting the increased work of breathing and the mechanical effort required to move air through the restricted bronchial passages.

Choice C rationale

An asthma cough is typically non-productive (dry) or, if secretions are present, it is often a mucoid, tenacious sputum. A consistently productive cough suggests other underlying conditions, such as infection (e.g., pneumonia) or bronchiectasis, rather than being the hallmark of a primary, mild-to-moderate asthma flare.

Choice D rationale

Wheezing, a high-pitched whistling sound, is the classic objective sign of asthma, caused by the vibration of air attempting to move rapidly through the severely narrowed, obstructed small airways (bronchioles) during respiration. It is often most prominent on expiration but can be present on inspiration during a significant episode.

Choice E rationale

Prolonged expiration occurs because the narrowed, inflamed airways obstruct the outflow of air, leading to air trapping and a higher residual volume. The patient must forcefully and slowly push air out against the resistance, making the expiratory phase last significantly longer than the inspiratory phase, a key sign of obstructive lung disease.